Harpoon Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Harpoon Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2022.
  • Harpoon Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $73.9M, a 16.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $73.9M +$10.5M +16.5% Dec 31, 2022 10-K 2023-03-27
Q4 2021 $63.5M +$18.8M +42.1% Dec 31, 2021 10-K 2023-03-27
Q4 2020 $44.7M +$12.5M +39.1% Dec 31, 2020 10-K 2022-03-10
Q4 2019 $32.1M +$17.9M +127% Dec 31, 2019 10-K 2021-03-10
Q4 2018 $14.2M +$6.5M +84.7% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $7.68M Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.